912 related articles for article (PubMed ID: 18840783)
41. Nitric oxide does not downregulate Rho-kinase (ROCK-2) expression in rat coronary endothelial cells.
Tiftik RN; Erol A; Cnar MG; Kubat H; Ark M; Ulker S; Büyükafşar K
J Cardiovasc Pharmacol; 2008 Feb; 51(2):140-7. PubMed ID: 18287881
[TBL] [Abstract][Full Text] [Related]
42. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
Pearson JT; Jenkins MJ; Edgley AJ; Sonobe T; Joshi M; Waddingham MT; Fujii Y; Schwenke DO; Tsuchimochi H; Yoshimoto M; Umetani K; Kelly DJ; Shirai M
Cardiovasc Diabetol; 2013 Aug; 12():111. PubMed ID: 24059472
[TBL] [Abstract][Full Text] [Related]
43. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
[TBL] [Abstract][Full Text] [Related]
44. Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway.
Li JR; Zhao YS; Chang Y; Yang SC; Guo YJ; Ji ES
PLoS One; 2018; 13(4):e0195604. PubMed ID: 29641598
[TBL] [Abstract][Full Text] [Related]
45. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
46. Fasudil, a Rho-Associated Protein Kinase Inhibitor, Attenuates Traumatic Retinal Nerve Injury in Rabbits.
Yu J; Luan X; Lan S; Yan B; Maier A
J Mol Neurosci; 2016 Jan; 58(1):74-82. PubMed ID: 26635024
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury.
Wang QM; Stalker TJ; Gong Y; Rikitake Y; Scalia R; Liao JK
Vasc Med; 2012 Dec; 17(6):379-85. PubMed ID: 23015643
[TBL] [Abstract][Full Text] [Related]
48. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina.
Kitaoka Y; Kitaoka Y; Kumai T; Lam TT; Kuribayashi K; Isenoumi K; Munemasa Y; Motoki M; Kobayashi S; Ueno S
Brain Res; 2004 Aug; 1018(1):111-8. PubMed ID: 15262212
[TBL] [Abstract][Full Text] [Related]
49. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.
Bivalacqua TJ; Champion HC; Usta MF; Cellek S; Chitaley K; Webb RC; Lewis RL; Mills TM; Hellstrom WJ; Kadowitz PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9121-6. PubMed ID: 15184671
[TBL] [Abstract][Full Text] [Related]
50. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954
[TBL] [Abstract][Full Text] [Related]
51. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures.
O E; Ahn HY; Kim HK; You JC; Shin JC; Joe YA
Int J Mol Med; 2011 Sep; 28(3):357-63. PubMed ID: 21567077
[TBL] [Abstract][Full Text] [Related]
52. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
[TBL] [Abstract][Full Text] [Related]
53. Rho kinase inhibition by fasudil exerts antioxidant effects in hypercholesterolemic rats.
Ma Z; Zhang J; Ji E; Cao G; Li G; Chu L
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):688-94. PubMed ID: 21711379
[TBL] [Abstract][Full Text] [Related]
54. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model.
Park K; Kim SW; Rhu KS; Paick JS
J Sex Med; 2006 Nov; 3(6):996-1003. PubMed ID: 17100932
[TBL] [Abstract][Full Text] [Related]
55. Role of the Rho/ROCK signaling pathway in the protective effects of fasudil against acute lung injury in septic rats.
Wang Y; Wang X; Liu W; Zhang L
Mol Med Rep; 2018 Nov; 18(5):4486-4498. PubMed ID: 30221694
[TBL] [Abstract][Full Text] [Related]
56. Investigating the effects of the Rho-kinase enzyme inhibitors AS1892802 and fasudil hydrochloride on the contractions of isolated pregnant rat myometrium.
Ergul M; Turgut NH; Sarac B; Altun A; Yildirim Ş; Bagcivan I
Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():45-50. PubMed ID: 27160814
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis.
Okamoto H; Yoshio T; Kaneko H; Yamanaka H
Arthritis Rheum; 2010 Jan; 62(1):82-92. PubMed ID: 20039418
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis.
Wang ZH; Zhu D; Xie S; Deng Y; Pan Y; Ren J; Liu HG
J Cardiovasc Pharmacol; 2017 Aug; 70(2):102-109. PubMed ID: 28437280
[TBL] [Abstract][Full Text] [Related]
59. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.
Komers R; Oyama TT; Beard DR; Tikellis C; Xu B; Lotspeich DF; Anderson S
Kidney Int; 2011 Feb; 79(4):432-42. PubMed ID: 20962741
[TBL] [Abstract][Full Text] [Related]
60. Suppression of diabetic retinopathy with angiopoietin-1.
Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
